MedTrace Logo

Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System

NCT07746531 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2026-08-05

No results posted yet for this study

Summary

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.

Conditions

  • Hysterectomy, Benign Uterine Diseases

Interventions

DEVICE

benign hysterectomy

Robotic-assisted and laparoscopic hysterectomy for benign disease with the DEXTER robotic surgery system.

Sponsors & Collaborators

  • Distalmotion SA

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-07
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07746531 on ClinicalTrials.gov